Good morning to all !!. :) :) This weeks is sta
Post# of 151837
(Total Views: 422)
Posted On: 03/02/2020 8:28:50 AM
Re: ClosetInvestor #19893
Good morning to all !!. 
This weeks is starting in really good news. Can't be any better from my perspective (well, maybe a little).
First of all: patient #5 is confirming !!! This is all we want to know at this stage (apart from hearing from patient #6, of course). But, I cannot emphasize this any more: the economical future of Leronlimab hinges now on this data and EVERY patient showing results (not necessary the, now normal to us, 0 CTC count, which is, by the way, very difficult to achieve) reducing the CTC counts pushes us much further towards the goal.
I was waiting for the CC to hear or ask the question about patient #5 and possibly # 6. I got the information now to me, this is more important that the other topics, so my anxious expectation of the call has been lowered significantly (in a very positive way).
Still it would be nice to know what the original CTC and EMT values recorded were.
And, yes, ClosetInvestor, the PR should had been ALL about patient #5. Period.
New data shows that Leronlimab continues to achieve dramatic reduction/stoppage of metastasis in Cancer patients confirming a new paradigm in cancer treatment "
This weeks is starting in really good news. Can't be any better from my perspective (well, maybe a little).
First of all: patient #5 is confirming !!! This is all we want to know at this stage (apart from hearing from patient #6, of course). But, I cannot emphasize this any more: the economical future of Leronlimab hinges now on this data and EVERY patient showing results (not necessary the, now normal to us, 0 CTC count, which is, by the way, very difficult to achieve) reducing the CTC counts pushes us much further towards the goal.
I was waiting for the CC to hear or ask the question about patient #5 and possibly # 6. I got the information now
to me, this is more important that the other topics, so my anxious expectation of the call has been lowered significantly (in a very positive way). Still it would be nice to know what the original CTC and EMT values recorded were.
And, yes, ClosetInvestor, the PR should had been ALL about patient #5. Period.
New data shows that Leronlimab continues to achieve dramatic reduction/stoppage of metastasis in Cancer patients confirming a new paradigm in cancer treatment "
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼